-
LXRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Lexicon Pharmaceuticals (LXRX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 34.55 mm | 34.55 mm | 34.55 mm | 34.55 mm | 34.55 mm | 34.55 mm |
Cash burn (monthly) | 355.33 k | (no burn) | 21.23 mm | 17.59 mm | 17.87 mm | 17.32 mm |
Cash used (since last report) | 1.43 mm | n/a | 85.40 mm | 70.76 mm | 71.89 mm | 69.66 mm |
Cash remaining | 33.12 mm | n/a | -50.85 mm | -36.21 mm | -37.34 mm | -35.11 mm |
Runway (months of cash) | 93.2 | n/a | -2.4 | -2.1 | -2.1 | -2.0 |
13F holders | Current |
---|---|
Total holders | 137 |
Opened positions | 25 |
Closed positions | 18 |
Increased positions | 46 |
Reduced positions | 21 |
13F shares | Current |
---|---|
Total value | 451.52 bn |
Total shares | 424.80 mm |
Total puts | 133.20 k |
Total calls | 458.50 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Artal | 136.18 mm | $213.80 bn |
Invus | 136.18 mm | $317.30 mm |
FMR | 49.87 mm | $78.29 bn |
Siren, L.L.C. | 38.92 mm | $61.10 bn |
Orbimed Advisors | 11.02 mm | $17.31 bn |
BlackRock | 10.13 mm | $15.91 bn |
Vanguard | 8.09 mm | $12.70 bn |
Geode Capital Management | 3.52 mm | $5.53 bn |
STT State Street | 2.47 mm | $3.88 bn |
NEA Management | 2.38 mm | $3.74 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Coiante Scott M | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 230,000 | 0.00 | 230,000 |
2 Dec 24 | Ivan Cheung | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 186,685 | 0.00 | 186,685 |